The cell cycle and drug discovery: The promise and the hope

Full text not archived in this repository.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Brooks, G. and La Thangue, N.B. (1999) The cell cycle and drug discovery: The promise and the hope. Drug Discovery Today, 4 (10). pp. 455-463. ISSN 1359-6446 doi: 10.1016/S1359-6446(99)01400-2

Abstract/Summary

In recent years, there have been major developments in the understanding of the cell cycle. It is now known that normal cellular proliferation is tightly regulated by the activation and deactivation of a series of proteins that constitute the cell cycle machinery. The expression and activity of components of the cell cycle can be altered during the development of a variety of diseases where aberrant proliferation contributes to the pathology of the illness. Apart from yielding a new source of untapped therapeutic targets, it is likely that manipulating the activity of such proteins in diseased states will provide an important route for treating proliferative disorders, and the opportunity to develop a novel class of future medicines.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/16321
Identification Number/DOI 10.1016/S1359-6446(99)01400-2
Refereed Yes
Divisions Life Sciences > School of Biological Sciences > Biomedical Sciences
Interdisciplinary centres and themes > Institute for Cardiovascular and Metabolic Research (ICMR)
Publisher Elsevier
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar